Nurix Therapeutics Statistics
NASDAQ: NRIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
22.73+0.13 (+0.58%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Nurix Therapeutics by the numbers
Nurix Therapeutics has a market capitalization of $2.36 billion based on 103.78M shares outstanding. With trailing EPS of $-3.46, Nurix Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.9% below its 50-day average and 15.6% above its 200-day average.
Average daily trading volume is 1.27M shares, or about $28.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NRIX valuation vs. peer median
| Metric | NRIX | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.36B | $2.29B | +3% |
| Avg. volume | 1.27M | 1.04M | +22% |
Peer median across 8 companies: IRON, LQDA, BHC, HRMY, SLS, PBH, IMNM, PHVS.
Valuation
- Market cap
- $2.36B
- EPS (TTM)
- $-3.46
- Shares outstanding
- 103.78M
Price and trading
- Previous close
- 22.60
- Open
- 22.43
- Day range
- 22.18 – 23.10
- 52-week range
- 9.00 – 28.23
- 52-week change
- +131.23%
- Beta
- —
- Volume
- 1.51M
- Average volume
- 1.27M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 8, 2026
Additional statistics
- Market Cap
- 2.36B
- Forward Pe
- -21.34
- Eps
- -3.46
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 28.23
- Week52 Low
- 9.00
- Avg Volume
- 1.27M
- Shares Outstanding
- 103.78M
- Ma50
- 25.23
- Ma200
- 19.65
- Earnings Date
- Oct 8, 2026
- Pct From52w High
- -19.48%
- Pct From52w Low
- 152.56%